Clinical trial · Interventional
Study on Indications of "Bard" PowerPort Isp Implantable Port
Study on Indications of "Bard" PowerPort Isp Implantable Port: Image Accuracy in Resectable Esophageal Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
For esophageal cancer patients,chest CT could provide more accurate staging information and eliminated operation that could not achieve R0 resection such as T4 disease. However, the variation image quality was usual encountered because of contrast medium was injected via peripheral vein. Power injectable port could provide a secure vascular access as administration route for contrast medium via central vein. This could provide higher intravascular contrast medium concentration and could lead better image quality. This study divided into two arms, one group planned to receive power injectable port and another received conventional port. The aim of study was tried to identified the image differences between different contrast medium administration route and the its survival impact of esophageal cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Image Accuracy | — | UNRESOLVED | — |
| Power Port | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| "Bard"PowerPort sip Implantable Port | Device | — | UNRESOLVED |
| Conventional Port | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Power Port
- description
- patients who received power injectable port
- interventionNames
- Device: "Bard"PowerPort sip Implantable Port
- type
- ACTIVE_COMPARATOR
- label
- Conventional Port
- description
- patients who received conventional port ( not power injectable)
- interventionNames
- Device: Conventional Port
Primary outcomes (3)
- measure
- Chest tomography (Before and after neoadjuvant therapy)
- timeFrame
- 1. before neoadjuvant CCRT ( just after diagnosis) 2. after neoadjuvant CCRT prior surgery intervention(for treatment response after neoadjuvant CCRT; 3~4 months after neoadjuvant CCRT.)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with esophageal cancer that in the clinical stage of T3\~4 N0\~2 M0 before treatment and presents no distant metastasis Exclusion Criteria: * Patients with esophageal cancer that in the clinical stage of TxN3M1 before treatment and presents no distant metastasis
References
Publications (26)
- BACKGROUNDCharvat J, Linke Z, Horaekova M, Prausova J. Implantation of central venous ports with catheter insertion via the right internal jugular vein in oncology patients: single center experience. Support Care Cancer. 2006 Nov;14(11):1162-5. doi: 10.1007/s00520-006-0073-2. Epub 2006 Apr 5. PMID 16596418
- BACKGROUNDCopper CM, Pacanowski JP, Bell JL. The trapezius port: a novel approach for port access. Am Surg. 2005 Feb;71(2):106-9. PMID 16022007
- BACKGROUNDBroviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet. 1973 Apr;136(4):602-6. No abstract available. PMID 4632149
- BACKGROUNDHickman RO, Buckner CD, Clift RA, Sanders JE, Stewart P, Thomas ED. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet. 1979 Jun;148(6):871-5. No abstract available. PMID 109934
- BACKGROUNDNiederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery. 1982 Oct;92(4):706-12. PMID 7123491
- BACKGROUNDBelzunegui T, Louis CJ, Torrededia L, Oteiza J. Extravasation of radiographic contrast material and compartment syndrome in the hand: a case report. Scand J Trauma Resusc Emerg Med. 2011 Feb 4;19:9. doi: 10.1186/1757-7241-19-9. PMID 21294896
- BACKGROUNDAzais H, Bresson L, Bassil A, Katdare N, Merlot B, Houpeau JL, El Bedoui S, Meurant JP, Tresch E, Narducci F. Chemotherapy drug extravasation in totally implantable venous access port systems: how effective is early surgical lavage? J Vasc Access. 2015 Jan-Feb;16(1):31-7. doi: 10.5301/jva.5000316. Epub 2014 Oct 16. PMID 25362986